However, in breast cancer, the TP53 mutant group exhibited higher TMB values (p < 0.001) and a significantly higher stromal score (p = 0.003); by contrast, KEGG and GSEA enrichment analyses of TP53 mutant breast cancer yielded different results (Zhang et al., 2021). The gene discussed is TP53; the disease is breast cancer.